Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Adher Al-Sayed"'
Autor:
Hazem Ghebeh, Adher Al-Sayed, Riham Eiada, Leilani Cabangon, Dahish Ajarim, Kausar Suleman, Asma Tulbah, Taher Al-Tweigeri
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Therapeutic anti-PD-L1 antibodies are safe as a monotherapy, albeit with minimal efficacy in triple-negative breast cancer (TNBC). This trial aimed to test the safety and efficacy of Durvalumab and Paclitaxel in metastatic TNBC. In this open
Externí odkaz:
https://doaj.org/article/4082da344ce44ce6b8b8a7859e11152b
Autor:
Kausar Suleman, Noha Jastaniyah, Tusneem Elhassan, Wafa Alkhayal, Osama Almalik, Ali Hassan Mushtaq, Adher Al-Sayed, Dahish Ajarim, Emaan Haque, Taher Al-Tweigeri, Ahmed Badran
Publikováno v:
Oncology. 98:168-173
Background:There is a paucity of literature examining the impact of timing of surgery after neoadjuvant chemotherapy. Objective:This study aimed to analyze the impact of the time taken to initiate surgical treatment following completion of neoadjuvan
Autor:
O Almalik, W Alkhayal, Adher Al-Sayed, NT Jastaniyah, AH Mushtaq, Kausar Suleman, Ahmed Badran, Dahish Ajarim, T Twegieri, T Elhassan, E. Haque
Publikováno v:
Cancer Research. 79:P2-14
Background: This study aims to analyze the impact of the time taken from the completion of neoadjuvant chemotherapy to surgery on patients' outcomes in terms of pathological response, overall survival and disease-free survival. There is no specific g
Autor:
Taher Al-Tweigeri, Adher Al-Sayed, Leilani Cabangon, Riham Eiada, Hazem Ghebeh, Asma Tulbah, Dahish Ajarim, Kausar Suleman
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Therapeutic anti-PD-L1 antibodies are safe as a monotherapy, albeit with minimal efficacy in triple-negative breast cancer (TNBC). This trial aimed to test the safety and efficacy of Durvalumab and Paclitaxel in metastatic TNBC. In this open-label, o
Autor:
Hazem Ghebeh, Adher Al-Sayed, Kauser Suleman, Riham Eiada Eiada, Asma Tulbah, Taher Al-Tweigeri
Publikováno v:
Cancer Immunology Research. 10:P070-P070
Weekly paclitaxel is an excellent therapeutic choice for metastatic triple-negative breast cancer, a type of cancer that typically has short survival. There is evidence that TNBC is relatively more immunogenic; THEREFORE, we tested the safety and eff
Publikováno v:
Cancer Immunology Research. 10:P059-P059
Background: Several trials have reported on eosinophilia in cancer patients receiving immunotherapy therapy of cancer especially checkpoint inhibitors. There is limited reports on eosinophilia and immunotherapy in triple-negative breast cancer (TNBC)
Autor:
Dahish Ajarim, Adher Al-Sayed, Emaan Haque, Ahmed Gad, Ayman Omar, Ahmed Badran, Ali Hassan Mushtaq, Ayman Elshentenawy, Ahmed Elashwah, Khurshid Ahmed Khan, Kausar Suleman, Amgad Shaheen Abdelsamad, Taher Al-Tweigeri
Publikováno v:
Breast Care (Basel)
Introduction: Human epidermal growth factor receptor 2 (HER-2) targeted therapy regimens can improve tumor response in HER-2-positive metastatic breast cancer (MBC), with overall survival benefits. Objective: We evaluated the efficacy of dual HER-2 b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9835273edbff89bb3588223f35d90cc6
https://europepmc.org/articles/PMC7923938/
https://europepmc.org/articles/PMC7923938/
Autor:
Adher Al-Sayed, Mahmoud A. Elshenawy, Dahish Ajarim, Ahmed Badran, Kausar Suleman, Taher Al-Tweigeri, Aisha Alshibany, Bader I Alshamsan
Publikováno v:
Journal of Clinical Oncology. 39:e12534-e12534
e12534 Background: Metaplastic breast cancer (MPBC) accounts for less than 1% of all breast cancer subtypes. Methods: Patients diagnosed with MPBC between 2001 are 2018 were reviewed. Disease characteristics, progression-free survival (PFS), and over
Autor:
Adher Al-Sayed, Kausar Suleman, Asma Tulbah, Asif Husain Osmani, Taher Al-Twegieri, Ali AlShanqeeti, Dahish Ajarim
Publikováno v:
The American Journal of Case Reports
Case series Patients: Female, 54-year-old • Female, 67-year-old • Female, 58-year-old • Female, 63-year-old • Female, 61-year-old • Female, 60-year-old • Female, 63-year-old • Female, 60-year-old • Female, 40-year-old Final Diagnosis:
Autor:
Asma Tulbah, Falah Al-Mohanna, Abdelilah Aboussekhra, Bothaina Al-Harbi, Adher Al-Sayed, Abdulaziz Jarman, Huda H. Al-Khalaf, Maria Arafah
Publikováno v:
Molecular and Cellular Biology. 39
Increasing evidence supports the critical role of active stromal adipocytes in breast cancer development and spread. However, the mediators and the mechanisms of action are still elusive. We show here that cancer-associated adipocytes (CAAs) isolated